AIM2 and colorectal cancer: On the other hand, silencing of AIM2 was associated with poor survival in colorectal cancer (Dihlmann et al., 2014), and promoted colon tumorigenesis via the activation of the Wnt and Akt pathways (Wilson et al., 2015).